| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Deborah M. Messemer is Director at ALLO, with reported holdings spanning 4 companies. From October 2018 to July 2026, the filings on record show 0 open-market purchases and 11 sales. Deborah M. Messemer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.6M at current prices.
Our model assigns Deborah M. Messemer a middling insider score of 63/100, based on 11 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of +9.9%.
Deborah M. Messemer's largest disclosed position is in PYPL as Director, worth about $1.2M. The PYPL filings lean toward selling, a net 8,217 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | ALLO Allogene Therapeutics, Inc. | Director | Sell10b5-1 | 18,640 | $2.70 | $50,316.82 | -23.0% | +44.2% | -28.9% |